SCHEMBL7019988

SCHEMBL7019988

Cc1c(C)n(C)c2c(=O)n(CCC(C)(S)CS)c(=O)[nH]c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7019989 1.00
SCHEMBL7014384 0.88
SCHEMBL7014385 0.88
SCHEMBL7022079 0.81 ADORA2B (0.30)
SCHEMBL7022074 0.81 ADORA2B (0.30)
SCHEMBL7020736 0.75
SCHEMBL7020738 0.75
SCHEMBL7019920 0.73
SCHEMBL7012478 0.73 ADORA3 (0.33)
SCHEMBL7012482 0.73 ADORA3 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003089416-A1 SUBSTITUTED PYRIMIDINE-2,4(1H,3H)-DIONES FOR USE AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS IBFB GMBH (DE) 2003-10-30 WO disclosed
EP-1357114-A1 Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP) IBFB GmbH Privates Institut für biomedizinische Forschung und Beratung (DE) 2003-10-29 EP disclosed